International Flavors & Fragrances Return on Investment 2010-2025 | IFF
Current and historical return on investment (ROI) values for International Flavors & Fragrances (IFF) over the last 10 years.
| International Flavors & Fragrances ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2025-03-31 |
$-0.34B |
$20.81B |
-1.52% |
| 2024-12-31 |
$0.77B |
$21.48B |
3.36% |
| 2024-09-30 |
$-1.90B |
$23.44B |
-8.10% |
| 2024-06-30 |
$-2.00B |
$22.89B |
-8.29% |
| 2024-03-31 |
$-2.04B |
$23.48B |
-8.14% |
| 2023-12-31 |
$-2.11B |
$23.83B |
-8.13% |
| 2023-09-30 |
$0.53B |
$26.17B |
1.96% |
| 2023-06-30 |
$-1.60B |
$26.86B |
-5.88% |
| 2023-03-31 |
$-1.54B |
$27.01B |
-5.44% |
| 2022-12-31 |
$-1.33B |
$28.06B |
-4.51% |
| 2022-09-30 |
$-1.26B |
$27.18B |
-4.14% |
| 2022-06-30 |
$1.03B |
$30.66B |
3.24% |
| 2022-03-31 |
$0.92B |
$31.70B |
2.86% |
| 2021-12-31 |
$0.59B |
$31.89B |
1.80% |
| 2021-09-30 |
$0.51B |
$32.29B |
1.89% |
| 2021-06-30 |
$0.36B |
$33.15B |
1.69% |
| 2021-03-31 |
$0.37B |
$33.01B |
2.36% |
| 2020-12-31 |
$0.57B |
$10.10B |
5.65% |
| 2020-09-30 |
$0.58B |
$9.98B |
5.80% |
| 2020-06-30 |
$0.62B |
$10.18B |
6.14% |
| 2020-03-31 |
$0.70B |
$9.79B |
6.86% |
| 2019-12-31 |
$0.67B |
$10.23B |
6.42% |
| 2019-09-30 |
$0.64B |
$10.08B |
6.16% |
| 2019-06-30 |
$0.62B |
$10.64B |
6.16% |
| 2019-03-31 |
$0.57B |
$10.58B |
6.95% |
| 2018-12-31 |
$0.58B |
$10.55B |
9.04% |
| 2018-09-30 |
$0.61B |
$8.37B |
13.13% |
| 2018-06-30 |
$0.60B |
$3.47B |
17.63% |
| 2018-03-31 |
$0.60B |
$3.46B |
17.74% |
| 2017-12-31 |
$0.55B |
$3.32B |
17.22% |
| 2017-09-30 |
$0.53B |
$3.39B |
17.18% |
| 2017-06-30 |
$0.50B |
$3.32B |
17.18% |
| 2017-03-31 |
$0.51B |
$2.82B |
18.06% |
| 2016-12-31 |
$0.55B |
$2.70B |
19.15% |
| 2016-09-30 |
$0.58B |
$2.81B |
20.39% |
| 2016-06-30 |
$0.61B |
$3.04B |
21.84% |
| 2016-03-31 |
$0.60B |
$3.01B |
22.10% |
| 2015-12-31 |
$0.59B |
$2.53B |
22.86% |
| 2015-09-30 |
$0.60B |
$2.65B |
23.41% |
| 2015-06-30 |
$0.60B |
$2.62B |
23.43% |
| 2015-03-31 |
$0.60B |
$2.51B |
23.78% |
| 2014-12-31 |
$0.59B |
$2.46B |
23.67% |
| 2014-09-30 |
$0.56B |
$2.58B |
22.36% |
| 2014-06-30 |
$0.55B |
$2.54B |
22.37% |
| 2014-03-31 |
$0.54B |
$2.45B |
22.45% |
| 2013-12-31 |
$0.52B |
$2.40B |
22.22% |
| 2013-09-30 |
$0.52B |
$2.37B |
23.05% |
| 2013-06-30 |
$0.51B |
$2.31B |
23.87% |
| 2013-03-31 |
$0.50B |
$2.23B |
24.26% |
| 2012-12-31 |
$0.49B |
$2.13B |
24.16% |
| 2012-09-30 |
$0.44B |
$1.93B |
22.32% |
| 2012-06-30 |
$0.43B |
$2.00B |
21.98% |
| 2012-03-31 |
$0.42B |
$1.98B |
21.40% |
| 2011-12-31 |
$0.43B |
$1.89B |
22.27% |
| 2011-09-30 |
$0.46B |
$1.96B |
24.39% |
| 2011-06-30 |
$0.46B |
$1.96B |
24.60% |
| 2011-03-31 |
$0.45B |
$1.89B |
24.63% |
| 2010-12-31 |
$0.42B |
$1.79B |
23.54% |
| 2010-09-30 |
$0.42B |
$1.76B |
24.05% |
| 2010-06-30 |
$0.39B |
$1.78B |
21.68% |
| 2010-03-31 |
$0.36B |
$1.75B |
20.12% |
| 2009-12-31 |
$0.34B |
$1.71B |
18.80% |
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Consumer Products - Misc. Discretionary |
$16.525B |
$12.440B |
|
Flavors & Fragrances is a global leader in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets. It has 4 business units: Nourish, Scent, Health & Biosciences and Pharma Solutions; comprising 3 platforms: Ingredients, Flavors & Food Designs. Ingredients provide texturizing solutions to the food industry, food protection solutions for food and beverage products, specialty soy & pea protein with value-added formulations, emulsifiers and sweeteners. Flavors provide a range of flavor compounds & natural taste solutions, and value-added spices and seasoning ingredients. Food Designs offer savory solution products. Health & Biosciences includes, Health, Cultures & Food Enzymes, Home & Personal Care, Animal Nutrition, Grain Processing and Microbial Control, with a biotechnology-driven portfolio of products that serve the health and wellness, food, consumer and industrial markets. Pharma Solutions produces cellulosics and alginates-based pharma excipients.
|
